| Parabilis Medicines, Inc. | 4.62M | US$149M | 10.0% |
| Praxis Precision Medicines, Inc. | 500K | US$146M | 9.8% |
| Rapport Therapeutics, Inc. | 2.46M | US$82.6M | 5.5% |
| Edgewise Therapeutics, Inc. | 1.86M | US$75.5M | 5.1% |
| BridgeBio Oncology Therapeutics, Inc. | 17.9M | US$73.3M | 4.9% |
| Erasca, Inc. | 5M | US$73.3M | 4.9% |
| BlossomHill Therapeutics, Inc. | 3.61M | US$67.4M | 4.5% |
| Adlai Nortye Group Ltd. | 3.98M | US$63.7M | 4.3% |
| Dianthus Therapeutics, Inc. | 500K | US$44M | 3.0% |
| Abivax SA | 425K | US$42.1M | 2.8% |
| Bright Minds Biosciences Inc. | 800K | US$39.9M | 2.7% |
| Electra Therapeutics, Inc. | 3.37M | US$37.9M | 2.5% |
| Oruka Therapeutics, Inc. | 400K | US$33.3M | 2.2% |
| Attovia Therapeutics, Inc. | 1.79M | US$30.7M | 2.1% |
| Sensei Biotherapeutics, Inc. | 1.03M | US$30.6M | 2.1% |
| Latigo Biotherapeutics, Inc. | 1.82M | US$30.3M | 2.0% |
| AgomAb Therapeutics NV | 2.47M | US$27.4M | 1.8% |
| Opus Genetics, Inc. | 5.5M | US$26.6M | 1.8% |
| Climb Bio, Inc. | 2.11M | US$24.2M | 1.6% |
| Freenome, Inc. | 1.43M | US$22.5M | 1.5% |
| MBX Biosciences, Inc. | 375K | US$22M | 1.5% |
| Biohaven Ltd. | 1.51M | US$20.2M | 1.4% |
| ADARx Pharmaceuticals, Inc. | 963K | US$19.2M | 1.3% |
| EyePoint, Inc. | 5.75M | US$18.8M | 1.3% |
| Tango Therapeutics, Inc. | 700K | US$17.5M | 1.2% |
| BridgeBio Pharma, Inc. | 250K | US$16.4M | 1.1% |
| Cue Biopharma, Inc. | 625K | US$16.2M | 1.1% |
| Corbus Pharmaceuticals Holdings, Inc. | 2.34M | US$16M | 1.1% |
| BioAge Labs, Inc. | 2.24M | US$15.9M | 1.1% |
| Alumis Inc. | 2.08M | US$15.3M | 1.0% |
| Olema Pharmaceuticals, Inc. | 1.75M | US$15.1M | 1.0% |
| Helix Acquisition Corp. III | 1.3M | US$13.8M | 0.93% |
| Spyre Therapeutics, Inc. | 125K | US$11.1M | 0.75% |
| Definium Therapeutics, Inc. | 275K | US$10.5M | 0.70% |
| Aclaris Therapeutics, Inc. | 1.75M | US$9.21M | 0.62% |
| Amylyx Pharmaceuticals, Inc. | 300K | US$8.73M | 0.59% |
| Cabaletta Bio, Inc. | 4.5M | US$8.64M | 0.58% |
| Inhibrx Biosciences, Inc. | 50,000 | US$5M | 0.34% |
| Kailera Therapeutics, Inc. | 400K | US$4.57M | 0.31% |
| Jade Biosciences, Inc. | 300K | US$4.21M | 0.28% |
| iBio, Inc. | 3.57M | US$4.21M | 0.28% |
| Tarsus Pharmaceuticals, Inc. | 50,000 | US$3.93M | 0.26% |
| Roivant Sciences Ltd. | 100K | US$3.66M | 0.25% |
| Enliven Therapeutics, Inc. | 75,000 | US$3.44M | 0.23% |
| Odyssey Therapeutics, Inc. | 125K | US$2.78M | 0.19% |
| Boundless Bio, Inc. | 940K | US$2.36M | 0.16% |
| Insmed Incorporated | 20,000 | US$2.28M | 0.15% |
| Braveheart Bio, Inc. | 70,000 | US$1.41M | 0.09% |
| Research Alliance Corporation III | 125K | US$1.35M | 0.09% |
| Arcutis Biotherapeutics, Inc. | 50,000 | US$1.32M | 0.09% |
| Arrowhead Pharmaceuticals, Inc. | 15,000 | US$982K | 0.07% |
| Cogent Biosciences, Inc. | 30,000 | US$961K | 0.06% |
| Structure Therapeutics, Inc. | 30,000 | US$938K | 0.06% |
| Vaxcyte, Inc. | 15,000 | US$854K | 0.06% |
| Altimmune, Inc. | 0 | US$0 | 0.00% |
| Crinetics Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Damora Therapeutics, Inc. | 0 | US$0 | 0.00% |